CB
Cahill Brian Joseph
Chief Financial Officer
OtherM
Browse the detailed record of transactions filed by Cahill Brian Joseph, Chief Financial Officer. Insider active across 1 company, notably Eagle Pharmaceuticals, INC.. Aggregated, 11 reports have been recorded. History available since 20 December 2021. The latest transaction was filed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
8,000 shares0Common StockSEC:0001209191-22-015022:0
805 shares@ US$45.030.98% mcap12.8% of flowCommon StockSEC:0001209191-22-007224:0
805 shares@ US$45.0325.5% of flowCommon StockSEC:0001209191-22-007224
626 shares@ US$45.940.78% mcap10.2% of flowCommon StockSEC:0001209191-22-006048:0
626 shares@ US$45.9420.5% of flowCommon StockSEC:0001209191-22-006048
263 shares@ US$50.639.4% of flowCommon StockSEC:0001209191-22-002882
263 shares@ US$50.630.36% mcap4.7% of flowCommon StockSEC:0001209191-22-002882:0
738 shares@ US$50.6926.3% of flowCommon StockSEC:0001209191-22-002417
738 shares@ US$50.691.01% mcap13.2% of flowCommon StockSEC:0001209191-22-002417:0
467 shares@ US$55.4218.3% of flowCommon StockSEC:0001209191-21-070845
467 shares@ US$55.420.70% mcap9.1% of flowCommon StockSEC:0001209191-21-070845:0
About Cahill Brian Joseph
Brian Joseph Cahill is the Chief Financial Officer of EAGLE PHARMACEUTICALS, INC. He is responsible for the financial management of the company, including budgeting and financial reporting, to ensure its sustainable growth.